Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Express Scripts
Boehringer Ingelheim

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012429

« Back to Dashboard

NDA 012429 describes THIOGUANINE, which is a drug marketed by Aspen Global Inc and is included in one NDA. It is available from one supplier. Additional details are available on the THIOGUANINE profile page.

The generic ingredient in THIOGUANINE is thioguanine. One supplier is listed for this compound. Additional details are available on the thioguanine profile page.
Summary for 012429
Applicant:Aspen Global Inc
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 012429
Medical Subject Heading (MeSH) Categories for 012429
Suppliers and Packaging for NDA: 012429
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THIOGUANINE thioguanine TABLET;ORAL 012429 NDA Aspen Global Inc. 76388-880 N 76388-880-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.